Is Oramed Pharmaceuticals Inc. overvalued?

Oramed Pharmaceuticals Inc. (ORMP) — key valuation metrics and fundamentals.

No verdict

Price

$4.48

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$183.3M

Dividend yield

5.9%

Return on equity

82.7%

Sector

Healthcare

Fair value compares ORMP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks